Eltek (ELTK) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Mar, 2026Executive summary
Revenue for 2025 reached $51.8 million, up 11% year-over-year, driven by strong demand in defense and medical sectors and an accelerated investment plan, though not yet at full potential.
Net profit for 2025 was $0.8 million ($0.12 per share), down from $4.2 million ($0.63 per share) in 2024, reflecting operational challenges and US dollar depreciation.
Q4 2025 revenue was $13.2 million (vs. $10.8 million in Q4 2024); Q4 net loss was $0.3 million, compared to a net profit of $23,000 in Q4 2024.
Major operational transformation included facility relocation, machinery upgrades, and workforce adjustments.
The company extended its manufacturing facility lease through 2039, receiving a payment to partially offset facility investments, which will reduce annual rental expenses.
Financial highlights
Gross profit for 2025 was $8 million (15% margin), down from $10.3 million (22% margin) in 2024.
Operating profit was $2.3 million, compared to $4.4 million in 2024.
EBITDA for 2025 was $4.5 million (8.7–9% margin), compared to $5.9 million (13% margin) in 2024.
Cash flow from operating activities was $0.6 million, down from $4.5 million in 2024; cash and equivalents at year-end were $2.5 million, down from $7.6 million in 2024.
Inventories increased to $11.2 million from $9.5 million year-over-year.
Outlook and guidance
Targeting annual revenue installed capacity of $60–$65 million at current market prices.
Gross margin improvement expected after completion and qualification of new plating lines, anticipated by mid-to-late 2026.
Pricing system updated to reflect US dollar depreciation; margin improvement expected within 4–5 months as new orders reflect updated rates.
Strategic investments in new plating lines and upgraded infrastructure are expected to expand capacity and support complex product families.
Management remains confident in long-term growth, particularly in defense, medical, and high-end industrial markets.
Latest events from Eltek
- Q3 2024 revenue up 14% to $13.5M, with strong defense demand and new dividend policy.ELTK
Q3 20243 Feb 2026 - Q2 profit and margins fell on product mix, but a 30% backlog rise signals H2 recovery.ELTK
Q2 20241 Feb 2026 - 2024 profit and margins declined amid disruptions, but investments target future growth.ELTK
Q4 202426 Dec 2025 - Q2 2025 revenue up 20% with higher margins, strong defense demand, and capacity expansion underway.ELTK
Q2 202523 Nov 2025 - Revenue up 8% to $12.8M, but gross margin fell to 17% amid higher costs and new equipment.ELTK
Q1 202521 Nov 2025 - Q3 2025 revenue rose sequentially, but net loss and margins declined due to currency impacts.ELTK
Q3 202519 Nov 2025